ilShinbiobase Co. Ltd (068330) — Cash Flow Quality Index
ilShinbiobase Co. Ltd (068330) has a Cash Flow Quality Index of 0.26x as of June 2026. Operating cash flow of ₩426.36 Million is below net income of ₩1.65 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore ilShinbiobase Co. Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ilShinbiobase Co. Ltd Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for ilShinbiobase Co. Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. See ilShinbiobase Co. Ltd balance sheet independence to measure how much of total assets are equity-financed.
Annual Cash Flow Quality Index for ilShinbiobase Co. Ltd (2014–2025)
Year-by-year earnings quality comparison for ilShinbiobase Co. Ltd. For the full cash flow conversion analysis, see how efficiently does ilShinbiobase Co. Ltd generate cash.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.10x | ₩5.27 Billion | ₩4.79 Billion | ▲ +1.6% |
| 2024 | 1.08x | ₩4.12 Billion | ₩3.81 Billion | ▲ +13.7% |
| 2023 | 0.95x | ₩5.92 Billion | ₩6.23 Billion | ▲ +37.0% |
| 2022 | 0.69x | ₩2.65 Billion | ₩3.82 Billion | ▼ -35.8% |
| 2021 | 1.08x | ₩6.74 Billion | ₩6.24 Billion | ▼ -4.8% |
| 2020 | 1.13x | ₩4.50 Billion | ₩3.97 Billion | ▼ -4.9% |
| 2019 | 1.19x | ₩5.55 Billion | ₩4.65 Billion | ▼ -22.7% |
| 2018 | 1.54x | ₩4.88 Billion | ₩3.16 Billion | ▲ +53.6% |
| 2017 | 1.00x | ₩2.11 Billion | ₩2.10 Billion | ▼ -10.1% |
| 2016 | 1.12x | ₩3.01 Billion | ₩2.69 Billion | ▲ +957.5% |
| 2015 | 0.11x | ₩270.22 Million | ₩2.56 Billion | ▼ -94.0% |
| 2014 | 1.77x | ₩3.33 Billion | ₩1.88 Billion | — |